Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Basic Sciences

Distribution and Properties of Type I and Type II Binding Proteins in the Cyclic Adenosine 3′:5′-Monophosphate-dependent Protein Kinase System in Wilms' Tumor

Fumiaki Nakajima, Shinsaku Imashuku, Judith Wilimas, John E. Champion and Alexander A. Green
Fumiaki Nakajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinsaku Imashuku
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith Wilimas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John E. Champion
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander A. Green
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published November 1984
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

We compared the relative amounts and properties of cyclic adenosine 3′:5′-monophosphate (cAMP)-binding proteins in surgical specimens of Wilms' tumor and normal kidney. Cytosolic fractions of both tissues contained type I and type II isozymes of cAMP-dependent protein kinase (adenosine triphosphate: protein phosphotransferase, EC 2.7.1.37). Among tumor samples, the mean ratio of type I to type II cAMP-binding activity was 2.76 ± 0.52 (S.D.) contrasted with 1.36 ± 0.23 for normal kidney (p < 0.001). The total soluble cAMP-binding activities in normal and malignant tissues differed only slightly. Photoaffinity labeling of cytosol from either tissue, using cyclic adenosine 3′:5′-[8-azido-32P]monophosphate, disclosed three cAMP-binding proteins (Mr 47,000, 51,000, and 55,000) that were identified as regulatory subunits of the holoenzyme. Three lower-molecular-weight proteins with unknown function were considered to be proteolytic products of the larger proteins. The Mr 47,000 protein, a monomeric regulatory subunit of type I kinase, was clearly the dominant protein in tumor specimens, but it was much less abundant in normal kidney. The temperature sensitivities of the cAMP-binding proteins and their dissociation constants for cyclic adenosine 3′:5′-[8-azido-32P]monophosphate incorporation did not differ appreciably between tumor and normal tissues. Wilms' tumor appears to have a full complement of regulatory subunits of cAMP-dependent protein kinase that are capable of normal cellular function.

Footnotes

  • ↵1 Supported by Childhood Cancer Center Support (Core) Grant CA-21765 and Grant CA-23099 from the National Cancer Institute, by the Ruby Levi Research Fund, and by the American Lebanese Syrian Associated Charities.

  • ↵2 To whom requests for reprints should be addressed, at Division of Hematology-Oncology, St. Judé Children's Research Hospital, P. O. Box 318, Memphis, TN 38101.

  • Received January 28, 1982.
  • Accepted August 13, 1984.
  • ©1984 American Association for Cancer Research.
PreviousNext
Back to top
November 1984
Volume 44, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Distribution and Properties of Type I and Type II Binding Proteins in the Cyclic Adenosine 3′:5′-Monophosphate-dependent Protein Kinase System in Wilms' Tumor
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Distribution and Properties of Type I and Type II Binding Proteins in the Cyclic Adenosine 3′:5′-Monophosphate-dependent Protein Kinase System in Wilms' Tumor
Fumiaki Nakajima, Shinsaku Imashuku, Judith Wilimas, John E. Champion and Alexander A. Green
Cancer Res November 1 1984 (44) (11) 5182-5187;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Distribution and Properties of Type I and Type II Binding Proteins in the Cyclic Adenosine 3′:5′-Monophosphate-dependent Protein Kinase System in Wilms' Tumor
Fumiaki Nakajima, Shinsaku Imashuku, Judith Wilimas, John E. Champion and Alexander A. Green
Cancer Res November 1 1984 (44) (11) 5182-5187;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Basic Sciences

  • Pharmacokinetics and Immune Response of 131I-Chimeric Mouse/Human B72.3 (Human γ4) Monoclonal Antibody in Humans
  • Structure and Expression of the β-Platelet-derived Growth Factor Receptor Gene in Human Tumor Cell Lines
  • Aberrations of the Tumor Suppressor p53 and Retinoblastoma Genes in Human Hepatocellular Carcinomas
Show more Basic Sciences

Articles

  • Pharmacokinetics and Immune Response of 131I-Chimeric Mouse/Human B72.3 (Human γ4) Monoclonal Antibody in Humans
  • Structure and Expression of the β-Platelet-derived Growth Factor Receptor Gene in Human Tumor Cell Lines
  • Aberrations of the Tumor Suppressor p53 and Retinoblastoma Genes in Human Hepatocellular Carcinomas
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement